
Logomix Biotechnology is a cellular system engineering company dedicated to redefining drug development as a scalable information science. Our proprietary platform, Geno-Writing™, serves as the critical interface in this transformation, enabling complex and large-scale digital genome designs to be rapidly and precisely written into the human genome. While advancing our internal program for Type 1 Diabetes, this technology functions as a a high-performance execution layer for global partners across diverse disease areas. Beyond therapeutic development, Geno-Writing™ fuels the Bio-AI stream by…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.